RecruitingNot ApplicableNCT06596759

Diaphragmatic Breathing for the Treatment of Bloating and Distension

Diaphragmatic Breathing for the Treatment of Bloating and Distension: a Prospective Pilot Study


Sponsor

Mayo Clinic

Enrollment

35 participants

Start Date

Oct 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the efficacy of diaphragmatic breathing using the validated Mayo Bloating Questionnaire.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Referred for breath testing for the indication of bloating.

Exclusion Criteria1

  • Not referred for breath testing for the indication of bloating.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDiaphragmatic Breathing

REDCap will be used to administer the Mayo Bloating Questionnaire (MBQ) and collect self-reported compliance to diaphragmatic breathing (DB) exercises over a 4 week follow up period. After completion of the MBQ, the patient will be taught DB techniques by an individual physical therapist face to face over a 30-minute session. The patient will be instructed to complete 5-10 minutes of diaphragmatic breathing twice a day for a period of 4 weeks. Patients will receive a telephone call and electronic health record portal message to check progress and answer any questions. At the end of the 4-week follow up period, patients will repeat the MBQ and self-report their adherence to daily diaphragmatic breathing. The questionnaire will include prompts investigating perceived side effects and attitudes towards therapy, willingness to perform DB therapy, likelihood to attempt self-guided DB in the future, and if the participant would recommend the therapy to a friend.


Locations(1)

Mayo Clinic in Florida

Jacksonville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06596759


Related Trials